Stock Market News for November 6, 2026

At a glance

On November 6, 2026, Vistra raised 2026 adjusted EBITDA guidance and approved an additional $1.5 billion buyback; Ubiquiti reported record fiscal Q1 revenue of $1,026.2 million; Moderna returned to profitability with Q3 revenue of $1.313 billion and raised its 2026 revenue-growth outlook; Firefly signed a $1.3 billion+ engine supply agreement.

Earnings and guidance

Vistra (VST) reported third-quarter 2026 net income and raised full-year adjusted EBITDA guidance to $7.1 billion–$7.5 billion, initiated 2027 guidance of $7.7 billion–$8.5 billion and announced an additional $1.5 billion buyback.

Ubiquiti (UI) reported record fiscal Q1 revenue of $1,026.2 million, with GAAP net income of $320.5 million and diluted EPS of $5.29 for the quarter ended September 30, 2026.

Charter Comm Inc Del CL A New (CHTR) reported third-quarter results and launched an operating overhaul targeting $2 billion in annualized operating expense savings over the next 18 months.

Moderna (MRNA) reported third-quarter 2026 revenue of $1.313 billion, returned to profitability with net income of $162 million and raised its 2026 revenue growth outlook to 15%–25%.

Humana (HUM) reported third-quarter results and raised full-year 2026 adjusted EPS guidance to at least $9.50, up from at least $9.00, while reporting a third-quarter adjusted loss of $0.70 per share.

Brookfield Asset Management (BAM) reported third-quarter fee-related earnings of $864 million, distributable earnings of $763 million and net income of $2,999 million, including a $2.0 billion non-cash gain.

Fluor (FLR) reported third-quarter 2026 revenue of $3.7 billion and net earnings attributable to Fluor of $158 million, returning to a quarterly profit.

Delek US Holdings (DK) reported third-quarter 2026 net income attributable to Delek of $1,133.8 million and adjusted EBITDA of $1,280.4 million, and raised its annual cash-flow improvement target to at least $250 million.

Elanco Animal Health (ELAN) reported third-quarter 2026 revenue of $1.265 billion, raised its full-year outlook and reported adjusted EBITDA of $243 million.

TeraWulf (WULF) reported third-quarter 2026 revenue of $76.230 million, with lease revenue of $62.986 million (about 83% of revenue) and net income attributable to TeraWulf of $709.912 million aided by valuation gains.

Deals and contracts

Firefly Aerospace (FLY) signed a supply and support agreement worth more than $1.3 billion to provide Miranda and Vira rocket engines and services to AST SpaceMobile over three years.

XTEND AI Robotics (XTND) received an approximately $8.3 million defense purchase order through its Asia‑Pacific subsidiary for unmanned aerial systems, ground control stations and a first‑year software update package.

Oklo (OKLO) agreed to reserve planned domestic manufacturing capacity with U.S. Forged Rings for Aurora reactor components, with initial finished component deliveries beginning in 2030 and capacity reserved through 2035.

Drug trials and regulatory

Pulse Biosciences (PLSE) presented six-month interim PRECISE-BTN results showing 86% of evaluated patients achieved the primary endpoint after a single nonthermal nsPFA treatment, with median nodule volume reduction of 72% at six months.

Satellos Bioscience (MSLE) changed the primary efficacy endpoint in its BASECAMP pediatric Duchenne trial to MRI‑measured muscle fat fraction in the vastus lateralis following FDA feedback and submitted a protocol amendment; topline data are expected in Q1 2027.

Corporate actions and listings

InMed Pharmaceuticals (INM) completed its merger with Mentari Therapeutics, changed its name to Mentari Therapeutics and said the combined company's shares are expected to begin trading as MTRI on Nasdaq on November 9, 2026.

ANTU (ANTU) announced that ProShares plans to launch two Anthropic‑linked ETFs—ProShares Ultra Anthropic (ANTU) and ProShares UltraShort Anthropic (ANTY)—targeting 2x and -2x daily returns following Anthropic’s IPO.

Cleveland-Cliffs (CLF) reached new four‑year labor agreements with the United Steelworkers covering approximately 12,000 employees, subject to ratification by USW locals.

Other notable news

Franklin Templeton (BEN) announced preliminary fourth‑quarter net income of $380.1 million and fiscal 2026 net income of $1,075.3 million, with diluted earnings of $1.97 for the year.

Dauch (DCH) reported a third‑quarter 2026 net loss of $45.3 million, while sales rose to $2,908.6 million following the Dowlais acquisition and adjusted EBITDA increased to $358.5 million.